文献速递炎症性肠病消化内镜消化道肿瘤与早癌

系统综述与病例系列:软式乙状结肠镜可识别大多数检查点抑制剂诱导的结肠炎

Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis.
PubMed 文献 · Aliment Pharmacol Ther · 2019-04-29

通过系统综述检索PubMed和Embase截至2017年1月3日的文献,纳入61项研究共226例经下消化道内镜诊断的检查点抑制剂诱导结肠炎,仅4例病变局限于左结肠近端;单中心回顾性分析31例(29例完整数据)显示左结肠均受累,软式乙状结肠镜可诊断超过98%的病例。

要点

  • 中重度检查点抑制剂诱导结肠炎多数(>98%)累及左结肠。
  • 系统综述中226例经下消化道内镜诊断的结肠炎仅4例病变位于左结肠近端。
  • 单中心31例中29例完整数据均显示左结肠受累。

核心结论

  • 中重度检查点抑制剂诱导结肠炎多数(>98%)累及左结肠,软式乙状结肠镜应作为评估该病的初始内镜方法。

研究设计与样本

  • 系统综述检索PubMed和Embase截至2017年1月3日的检查点抑制剂诱导结肠炎病例报告和系列。
  • 单中心回顾性病历审查纳入2011年1月1日至2017年1月3日期间接受伊匹木单抗、纳武利尤单抗或帕博利珠单抗治疗后因腹泻行内镜评估的患者。

主要发现

  • 系统综述纳入61项研究,共226例经下消化道内镜诊断的结肠炎(125例结肠镜,101例乙状结肠镜),仅4例病变局限于左结肠近端。
  • 本中心31例有检查点抑制剂诱导结肠炎的组织学特征,其中29例数据完整,左结肠均受累。
  • 软式乙状结肠镜足以诊断已报道的经下消化道内镜诊断的检查点抑制剂介导结肠炎病例的>98%。

关键数值与推荐

  • 系统综述中226例经下消化道内镜诊断的结肠炎仅4例病变位于左结肠近端。
  • 本中心29例完整数据中左结肠均受累。

临床怎么用

  • 作者结论认为软式乙状结肠镜应作为评估检查点抑制剂诱导结肠炎的初始内镜方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immune checkpoint inhibitors are used in the treatment of multiple advanced stage cancers but can induce immune-mediated colitis necessitating treatment with immunosuppressive medications. Diagnostic colonoscopy is often performed but requires bowel preparation and may delay diagnosis and treatment. Sigmoidoscopy can be performed rapidly without oral bowel preparation or sedation. AIMS: Characterize the colonic distribution of immune-mediated colitis to determine the most efficient endoscopic approach. METHODS: A systematic review of checkpoint inhibitor-induced colitis case reports and series was conducted in both PubMed and Embase through 3 January 2017. A single centre retrospective chart review of patients who underwent endoscopic evaluation for diarrhoea after treatment with a checkpoint inhibitor (ipilimumab, nivolumab or pembrolizumab) between 1 January 2011 and 3 January 2017 was performed. Clinical, endoscopic and histologic data were collected. RESULTS: A detailed systematic review resulted in 61 studies, in which 226 cases of colitis were diagnosed by lower endoscopy (125 colonoscopy, 101 sigmoidoscopy). Only four patients had isolated findings proximal to the left colon. In our centre, 31 patients had histologic features of checkpoint inhibitor-induced colitis, for which 29 patients had complete data. The left colon was involved in all cases. Sigmoidoscopy would be sufficient to diagnose >98% of reported cases of checkpoint inhibitor-mediated colitis diagnosed by lower endoscopy. CONCLUSIONS: Moderate to severe checkpoint inhibitor-induced colitis involves the left colon in the majority of cases (>98%). Sigmoidoscopy should be the initial endoscopic procedure in the evaluation of this condition.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Wright AP, Piper MS, Bishu S, et al. Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis. Aliment Pharmacol Ther. 2019. PMID: 31035308. doi:10.1111/apt.15263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。